Navigation Links
Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
Date:11/2/2007

-Nucleoside polymerase inhibitor demonstrates >99% mean decrease in HCV RNA

with no serious adverse events-

PRINCETON, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces the results of a 14-day Phase 1 multiple ascending dose monotherapy study of R7128 for the treatment of chronic hepatitis C infection. In this study, being presented as a "late-breaker" abstract at the 58th Annual Meeting of the American Association for the Study of Liver Diseases, R7128 demonstrated potent antiviral activity and was generally safe and well-tolerated. R7128 is an orally administered prodrug of PSI-6130, a cytidine nucleoside analogue polymerase inhibitor of hepatitis C virus (HCV) that is being developed through Pharmasset's collaboration with Roche.

"R7128 has provided positive proof-of-concept that a single, direct-acting antiviral can deliver sufficient potency to suppress HCV in an interferon non- responder population," stated Dr. Michelle Berrey, Pharmasset's Vice President, Clinical Development & Chief Medical Officer. "Since robust synergy has been observed with other potent inhibitors when combined with the standard of care for HCV, we hope that these monotherapy results will translate well when R7128 is used with standard of care for longer duration in a treatment-naive population."

Dr. Rajender Reddy, Professor of Medicine and Surgery in the Division of Gastroenterology at the University of Pennsylvania and a clinical investigator in the study, noted "R7128's safety profile is encouraging, with no serious or treatment-limiting adverse events reported even at the highest dose tested. In addition, there were actually a higher number of adverse events reported
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
8. Combination Therapy More Effective Than Monotherapy for Treating Migraine
9. Rural Canadians travel far for specialists: study
10. A new study surpasses Gene Therapy Hurdle
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... by the Engineering and Physical Sciences Research Council ... UK,s vital industrial control systems which run, for ... and the rail network. , The research ... or malware infiltrating the systems behind our critical ... Trustworthy Industrial Control Systems (RITICS), based at Imperial ...
(Date:10/1/2014)... Despite a policy focus on expanding access ... vulnerable population continues to have significant dental disease. ... of the American Dental Association , researchers from ... School of Dental Medicine report on the first ... care provided by caregivers to adults with developmental ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new blog post explaining ... , Senior citizens can qualify for affordable term life ... who are over 50 years old. Some term life ... examination. , Term life insurance with a simplified issue ... Having life insurance during retirement is important for covering ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Insuranceragents.info ... find a good life insurance plan for vulnerable family ... for vulnerable family members. Providers in the family should ... will cause financial hardships for the rest of the ... of policies. Families can benefit more from temporary coverage ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post explaining ... smokers. , Smoking will always have a negative impact ... best method to find affordable coverage. Insurance brokerage websites ... , Whole life insurance premiums will be fixed ... coverage is permanent, the initial rates are very ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2
... ... adherence and effectiveness during NACDS Annual Meeting , ... Palm Beach, FL (Vocus) April 27, 2010 -- In his first remarks ... Drug Stores ( NACDS ), Larry J. Merlo, president of CVS/pharmacy, paid tribute to ...
... Psychopaths are known to be characterized by callousness, diminished ... exact cause of these personality traits is an area ... study, reported in the May 2010 issue of Elsevier,s ... between the mental impairments observed in psychopaths and those ...
... ... Florida to Use Via Oncology Pathways to Ensure the Best Treatment for Each Patient ... ... a subsidiary of the University of Pittsburgh Medical Center (UPMC), announced that Space Coast ...
... , ... chewy, preservative-free snacks that are low-calorie, low in sugar and high in antioxidants. Summer is just ... cookies. Go ahead and kick Summer off with the healthiest berry on earth! , ... New York, NY (PRWEB) April 26, 2010 -- Move ...
... for men with advanced disease, studies found, , TUESDAY, ... week of a therapeutic prostate cancer vaccine by the ... against the disease and cancer in general, experts say. ... in men with advanced prostate cancer, and it does ...
... ... 2-1 that they would re-elect President Obama over former Massachusetts Governor Mitt Romney and former ... ... ., the leading conference, training and publishing company for direct-to-consumer (DTC) marketing, today revealed that ...
Cached Medicine News:Health News:New NACDS Chairman Larry Merlo Emphasizes Personal Commitment, Connection to Pharmacy 2Health News:New NACDS Chairman Larry Merlo Emphasizes Personal Commitment, Connection to Pharmacy 3Health News:An underlying cause for psychopathic behavior? 2Health News:Space Coast Cancer Center Selects Via Oncology™ Pathways to Advance Evidence-Based Cancer Care 2Health News:Space Coast Cancer Center Selects Via Oncology™ Pathways to Advance Evidence-Based Cancer Care 3Health News:Space Coast Cancer Center Selects Via Oncology™ Pathways to Advance Evidence-Based Cancer Care 4Health News:Supercharge Summer with Superfood-infused Cookies! 2Health News:Supercharge Summer with Superfood-infused Cookies! 3Health News:Prostate Cancer Vaccine May Get FDA Approval 2Health News:Prostate Cancer Vaccine May Get FDA Approval 3Health News:Top DTC Marketers Choose Obama Over Romney and Palin 2Health News:Top DTC Marketers Choose Obama Over Romney and Palin 3
(Date:10/2/2014)... -- MinuteClinic, the largest and fastest growing provider of retail medical clinics ... first walk-in clinics in the Corpus Christi ... and Portland . A third clinic ... The clinics are part of MinuteClinic,s national expansion plan ... Corpus Christi -area openings, there are now more than ...
(Date:10/2/2014)... 2014   Mast Therapeutics, Inc. (NYSE MKT: ... Edwin L. Parsley , D.O. has joined the Company ... Dr. Parsley has been actively engaged with ... February 2014.  He has served as Mast,s interim Chief ... Officer of Aires since April 2011.  Dr. Parsley previously ...
(Date:10/1/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... agreement with Patterson Veterinary Supply. Patterson ... of Abaxis veterinary products throughout the United ...
Breaking Medicine Technology:First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
... N.J., Oct. 26, 2011 Pharmaceutical gurus know that the ... is to get together with the field,s leading experts. And ... popular event that takes place just once a year: the ... 7-8 at the Hilton Parsippany Hotel in Parsippany, New Jersey. ...
... the leading innovator in epicardial ablation devices, announced today ... and www.ncontactinc.com . The design of the ... and the market for treating cardiac arrhythmias that affect ... are excellent educational references that highlight how our technology ...
Cached Medicine Technology:Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event 2nContact, Inc. Launches New Corporate Websites 2
Foldable Hydrophilic IOL with UV Absorber....
The STAAR ELASTIC LENS®, is a single piece silicone lens to be placed completely in the capsular bag....
... Engineers at Pfizer used wavefront sensing ... Optic Technology. Innovative TECNIS features a patented ... spherical aberration, which compensates for the positive ... result, TECNIS is the first and only ...
... PhacoFlexII SI30NB is foldable silicone ... it's patients. It is used ... SI30NB is indicated for primary ... of aphakia in adults (over ...
Medicine Products: